Cerevel Therapeutics

-$0.98 (-2.44%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERE and other ETFs, options, and stocks.

About CERE

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease.

CEO
N. Anthony Coles
Employees
104
Headquarters
Cambridge, Massachusetts
Founded
—

CERE Key Statistics

Market Cap
5.67B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
313.45K
High Today
$40.74
Low Today
$38.94
Open Price
$39.52
Volume
341.48K
52 Week High
$41.10
52 Week Low
$9.00

CERE Earnings

-$0.45
-$0.30
-$0.15
-$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure